CAICaris Life Sciences, Inc.

$5B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$250M+9.7% YoY

Gross Profit

$126M50.4% margin

Operating Income

$68M27.3% margin

Net Income

$27M10.7% margin

EPS (Diluted)

$1.28

Cash Flow

Operating Cash Flow

$147M

Free Cash Flow

-$242M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.5B

Stockholders' Equity

$460M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$250M	$228M	+9.7%
Gross Profit	$126M	$150M	-15.8%
Operating Income	$68M	$97M	-29.8%
Net Income	$27M	$60M	-55.5%

CAI FY 2015 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena